Cecilia Garlanda graduated in Veterinary Medicine, at the University of Milan, Italy. She worked at the Mario Negri Institute for Pharmacological Research in the Laboratory of Immunology, Milan, from 1990 to 2005, and at the Département de Biologie Moléculaire et Structurale in Grenoble, France, in 1994-1995. Since 2005, she is the Head of the Laboratory of Experimental Immunopathology of Humanitas Research Hospital and is currently Associate Professor of Clinical Pathology at Humanitas University, Milan, Italy.
Scientific activity is documented by several congress attendances or courses as invited speaker, 187 scientific publications on international journals, 17 chapters on scientific books, several abstracts at congresses; total H index 62; 15888 citations (Scopus).
Current research projects are focused on the functional characterization of innate immunity molecules identified by the Laboratory, such as the long pentraxin PTX3, and IL-1R8, a negative regulator of the IL-1 receptor family, in innate responses to pathogens and in the regulation of inflammation, particularly in cancer-associated inflammation and immunosurveillance in cancer. The activities of the Laboratory consist mainly of preclinical studies and are aimed at the identification of novel mechanisms involved in infections and cancer-related inflammation and at the possibility of transferring the information obtained to the clinic.